Kala Pharmaceuticals Inc. buy BiotechBee
Start price
28.09.25
/
80%
€16.56
Target price
30.09.27
€28.00
Performance (%)
-93.39%
End price
18.10.25
€1.09
Summary
This prediction ended on 18.10.25 with a price of €1.09. The BUY prediction by BiotechBee for Kala Pharmaceuticals Inc. performed very badly with a performance of -93.39%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | -20.171% | -20.171% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
According to BiotechBee what are the pros and cons of Kala Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kala Pharmaceuticals diskutieren
Buy mit Kursziel 28,0
In the thread Trading Kala Pharmaceuticals
Stopped prediction by BiotechBee for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.11
21.07.25
21.07.25
€8.00
27.06.27
27.06.27
224.39%
28.09.25
28.09.25
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.51
23.10.24
23.10.24
€6.50
28.02.27
28.02.27
5.26%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.24
08.09.24
08.09.24
€8.00
30.04.27
30.04.27
5.25%
23.10.24
23.10.24
Could be very worthwhile Investment >20% year